-
Stoke Therapeutics' (STOK) "Buy" Rating Reiterated at Chardan Capital
Источник: Buzz FX / 20 мар 2025 08:16:17 America/New_York
Stoke Therapeutics' (STOK) "Buy" Rating Reiterated at Chardan Capital Written by MarketBeat March 20, 2025 Share Link copied to clipboard. Remove Ads Stoke Therapeutics ( NASDAQ:STOK - Get Free Report ) 's stock had its "buy" rating restate
Read more...